Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02057133
Title A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.